HEADER IMMUNE SYSTEM 04-OCT-09 3K3Q TITLE CRYSTAL STRUCTURE OF A LLAMA ANTIBODY COMPLEXED WITH THE C. BOTULINUM TITLE 2 NEUROTOXIN SEROTYPE A CATALYTIC DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: LLAMA AA1 VHH DOMAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: BOTULINUM NEUROTOXIN TYPE A; COMPND 7 CHAIN: B; COMPND 8 FRAGMENT: N-TERMINAL FRAGMENT OF BONT CATALYTIC DOMAIN (RESIDUES 3- COMPND 9 250); COMPND 10 SYNONYM: BONT/A, BONTOXILYSIN-A, BOTOX, BOTULINUM NEUROTOXIN A LIGHT COMPND 11 CHAIN; COMPND 12 EC: 3.4.24.69; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: BOTULINUM NEUROTOXIN TYPE A; COMPND 16 CHAIN: C; COMPND 17 FRAGMENT: C-TERMINAL FRAGMENT OF BONT CATALYTIC DOMAIN (RESIDUES 251- COMPND 18 425); COMPND 19 SYNONYM: BONT/A, BONTOXILYSIN-A, BOTOX, BOTULINUM NEUROTOXIN A LIGHT COMPND 20 CHAIN; COMPND 21 EC: 3.4.24.69; COMPND 22 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LAMA GLAMA; SOURCE 3 ORGANISM_TAXID: 9844; SOURCE 4 GENE: LLAMA VHH IMMUNOGLOBULIN; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET20B; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: CLOSTRIDIUM BOTULINUM A STR. HALL; SOURCE 12 ORGANISM_TAXID: 441771; SOURCE 13 GENE: BOTA, CBO0806, CLC_0862, NEUROTOXIN CATALYTIC DOMAIN; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: CLOSTRIDIUM BOTULINUM A STR. HALL; SOURCE 21 ORGANISM_TAXID: 441771; SOURCE 22 GENE: BOTA, CBO0806, CLC_0862, NEUROTOXIN CATALYTIC DOMAIN; SOURCE 23 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 24 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 25 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 26 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 27 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS LLAMA, VHH, ANTIBODY, BOTULINUM, NEUROTOXIN, BONT, CELL JUNCTION, KEYWDS 2 CELL MEMBRANE, CYTOPLASM, DISULFIDE BOND, HYDROLASE, MEMBRANE, KEYWDS 3 METAL-BINDING, METALLOPROTEASE, PHARMACEUTICAL, PROTEASE, SECRETED, KEYWDS 4 SYNAPSE, TOXIN, TRANSMEMBRANE, ZINC, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR A.A.THOMPSON,J.DONG,J.D.MARKS,R.C.STEVENS REVDAT 3 01-NOV-17 3K3Q 1 REMARK REVDAT 2 07-APR-10 3K3Q 1 JRNL REVDAT 1 23-FEB-10 3K3Q 0 JRNL AUTH J.DONG,A.A.THOMPSON,Y.FAN,J.LOU,F.CONRAD,M.HO,M.PIRES-ALVES, JRNL AUTH 2 B.A.WILSON,R.C.STEVENS,J.D.MARKS JRNL TITL A SINGLE-DOMAIN LLAMA ANTIBODY POTENTLY INHIBITS THE JRNL TITL 2 ENZYMATIC ACTIVITY OF BOTULINUM NEUROTOXIN BY BINDING TO THE JRNL TITL 3 NON-CATALYTIC ALPHA-EXOSITE BINDING REGION. JRNL REF J.MOL.BIOL. V. 397 1106 2010 JRNL REFN ISSN 0022-2836 JRNL PMID 20138889 JRNL DOI 10.1016/J.JMB.2010.01.070 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.4 REMARK 3 NUMBER OF REFLECTIONS : 21269 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.400 REMARK 3 FREE R VALUE TEST SET COUNT : 1029 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4287 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 1 REMARK 3 SOLVENT ATOMS : 70 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.72 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -13.24500 REMARK 3 B22 (A**2) : -1.28000 REMARK 3 B33 (A**2) : 14.52500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.48100 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM SIGMAA (A) : 0.48 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.48 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.469 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.565 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.992 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.157 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 20.54 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : CNS_TOPPAR:PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CNS_TOPPAR:WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : CNS_TOPPAR:ION.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3K3Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-OCT-09. REMARK 100 THE DEPOSITION ID IS D_1000055507. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-OCT-08 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.033 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL CRYO-COOLED REMARK 200 SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22641 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : 2.800 REMARK 200 R MERGE (I) : 0.11700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.9 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.31400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.160 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.92 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% ETHYLENE GLYCOL, PH 7.0, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 84.14100 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.38200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 84.14100 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 24.38200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE IT IS POSSIBLE THAT A HEXAMER EXISTS IN REMARK 300 SOLUTION, BUT THIS WOULD BE IN EQUILIBRIUM WITH THE TRIMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 21780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 45440 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -223.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -168.28200 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24590 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -95.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASP A 2 REMARK 465 ILE A 3 REMARK 465 ALA A 141 REMARK 465 ALA A 142 REMARK 465 ALA A 143 REMARK 465 LEU A 144 REMARK 465 GLU A 145 REMARK 465 HIS A 146 REMARK 465 HIS A 147 REMARK 465 HIS A 148 REMARK 465 HIS A 149 REMARK 465 HIS A 150 REMARK 465 HIS A 151 REMARK 465 MET B -1 REMARK 465 ALA B 0 REMARK 465 VAL B 1 REMARK 465 LEU B 200 REMARK 465 GLU B 201 REMARK 465 VAL B 202 REMARK 465 ASP B 203 REMARK 465 THR B 204 REMARK 465 ASN B 205 REMARK 465 PRO B 206 REMARK 465 LEU B 207 REMARK 465 LEU B 208 REMARK 465 GLY B 209 REMARK 465 ALA B 210 REMARK 465 TYR C 251 REMARK 465 GLU C 252 REMARK 465 ASN C 418 REMARK 465 PHE C 419 REMARK 465 THR C 420 REMARK 465 GLY C 421 REMARK 465 LEU C 422 REMARK 465 PHE C 423 REMARK 465 GLU C 424 REMARK 465 PHE C 425 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 32 40.96 38.14 REMARK 500 ASP A 33 46.23 -104.01 REMARK 500 THR A 44 42.55 -106.91 REMARK 500 ALA A 45 147.52 -173.28 REMARK 500 VAL A 62 -72.78 -113.63 REMARK 500 GLU A 76 -37.27 -29.85 REMARK 500 LEU A 78 31.61 -148.08 REMARK 500 ARG A 81 -2.54 -161.50 REMARK 500 ALA A 88 -35.17 -38.66 REMARK 500 ALA A 90 55.41 76.75 REMARK 500 THR A 91 12.79 -148.20 REMARK 500 ALA A 97 138.53 -171.60 REMARK 500 THR A 105 113.59 -35.88 REMARK 500 ALA A 106 -175.18 175.89 REMARK 500 SER A 139 -157.77 -131.01 REMARK 500 LYS B 6 172.39 -57.91 REMARK 500 TYR B 10 -44.43 -29.65 REMARK 500 ASN B 15 -1.96 -140.90 REMARK 500 ASN B 26 27.74 -75.54 REMARK 500 ASP B 49 84.18 -64.92 REMARK 500 PHE B 51 -20.06 -140.84 REMARK 500 GLU B 56 -153.32 -103.96 REMARK 500 PRO B 62 177.03 -56.42 REMARK 500 GLU B 64 -90.69 -100.95 REMARK 500 GLN B 67 49.76 -65.68 REMARK 500 SER B 71 132.06 -174.10 REMARK 500 ASP B 74 117.37 179.10 REMARK 500 SER B 100 0.83 -57.97 REMARK 500 SER B 143 -162.97 -69.42 REMARK 500 TYR B 144 135.97 -176.23 REMARK 500 SER B 157 -148.48 -85.23 REMARK 500 SER B 167 134.96 -176.58 REMARK 500 VAL B 172 -73.04 -91.11 REMARK 500 THR C 306 1.46 87.62 REMARK 500 THR C 307 -79.41 -49.40 REMARK 500 ALA C 308 -155.39 -144.55 REMARK 500 ASN C 377 88.24 -164.20 REMARK 500 ASN C 410 -19.99 -49.18 REMARK 500 PHE C 413 73.65 -152.24 REMARK 500 LEU C 416 -156.30 -105.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 251 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 223 NE2 REMARK 620 2 HIS B 227 NE2 95.6 REMARK 620 3 GLU C 262 OE1 85.2 96.3 REMARK 620 4 GLU C 262 OE2 143.3 96.7 59.2 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 251 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THERE IS A VAL -> ALA NATURAL VARIANT AT RESIDUE 27. DBREF 3K3Q B 3 250 UNP A5HZZ9 BXA1_CLOBH 3 250 DBREF 3K3Q C 251 425 UNP A5HZZ9 BXA1_CLOBH 251 425 DBREF 3K3Q A 1 151 PDB 3K3Q 3K3Q 1 151 SEQADV 3K3Q MET B -1 UNP A5HZZ9 EXPRESSION TAG SEQADV 3K3Q ALA B 0 UNP A5HZZ9 EXPRESSION TAG SEQADV 3K3Q VAL B 1 UNP A5HZZ9 EXPRESSION TAG SEQADV 3K3Q GLN B 2 UNP A5HZZ9 EXPRESSION TAG SEQADV 3K3Q VAL B 27 UNP A5HZZ9 ALA 27 SEE REMARK 999 SEQRES 1 A 151 MET ASP ILE ALA VAL GLN LEU VAL ASP SER GLY GLY GLY SEQRES 2 A 151 THR LEU GLN ALA GLY LYS SER LEU ARG LEU SER CYS ALA SEQRES 3 A 151 ILE SER GLY LEU ALA PHE ASP GLY GLY ALA MET GLY SER SEQRES 4 A 151 GLU HIS ARG LEU THR ALA GLY ALA MET GLY TRP PHE ARG SEQRES 5 A 151 GLN ALA PRO GLY LYS ASP ARG GLU PHE VAL ALA ALA ILE SEQRES 6 A 151 SER PRO ARG THR ASP GLU THR TYR TYR ALA GLU SER LEU SEQRES 7 A 151 GLU GLY ARG PHE SER VAL SER ARG ASP ALA ALA ALA THR SEQRES 8 A 151 MET VAL PHE LEU GLN ALA ASP ASN VAL ARG LEU ASP ASP SEQRES 9 A 151 THR ALA SER TYR TYR CYS ALA ALA ASP GLU ASP VAL THR SEQRES 10 A 151 PRO ARG VAL MET GLY VAL ILE PRO HIS ALA ASP HIS TRP SEQRES 11 A 151 GLY GLN GLY THR LEU VAL THR VAL SER SER ALA ALA ALA SEQRES 12 A 151 LEU GLU HIS HIS HIS HIS HIS HIS SEQRES 1 B 252 MET ALA VAL GLN PHE VAL ASN LYS GLN PHE ASN TYR LYS SEQRES 2 B 252 ASP PRO VAL ASN GLY VAL ASP ILE ALA TYR ILE LYS ILE SEQRES 3 B 252 PRO ASN VAL GLY GLN MET GLN PRO VAL LYS ALA PHE LYS SEQRES 4 B 252 ILE HIS ASN LYS ILE TRP VAL ILE PRO GLU ARG ASP THR SEQRES 5 B 252 PHE THR ASN PRO GLU GLU GLY ASP LEU ASN PRO PRO PRO SEQRES 6 B 252 GLU ALA LYS GLN VAL PRO VAL SER TYR TYR ASP SER THR SEQRES 7 B 252 TYR LEU SER THR ASP ASN GLU LYS ASP ASN TYR LEU LYS SEQRES 8 B 252 GLY VAL THR LYS LEU PHE GLU ARG ILE TYR SER THR ASP SEQRES 9 B 252 LEU GLY ARG MET LEU LEU THR SER ILE VAL ARG GLY ILE SEQRES 10 B 252 PRO PHE TRP GLY GLY SER THR ILE ASP THR GLU LEU LYS SEQRES 11 B 252 VAL ILE ASP THR ASN CYS ILE ASN VAL ILE GLN PRO ASP SEQRES 12 B 252 GLY SER TYR ARG SER GLU GLU LEU ASN LEU VAL ILE ILE SEQRES 13 B 252 GLY PRO SER ALA ASP ILE ILE GLN PHE GLU CYS LYS SER SEQRES 14 B 252 PHE GLY HIS GLU VAL LEU ASN LEU THR ARG ASN GLY TYR SEQRES 15 B 252 GLY SER THR GLN TYR ILE ARG PHE SER PRO ASP PHE THR SEQRES 16 B 252 PHE GLY PHE GLU GLU SER LEU GLU VAL ASP THR ASN PRO SEQRES 17 B 252 LEU LEU GLY ALA GLY LYS PHE ALA THR ASP PRO ALA VAL SEQRES 18 B 252 THR LEU ALA HIS GLU LEU ILE HIS ALA GLY HIS ARG LEU SEQRES 19 B 252 TYR GLY ILE ALA ILE ASN PRO ASN ARG VAL PHE LYS VAL SEQRES 20 B 252 ASN THR ASN ALA TYR SEQRES 1 C 175 TYR GLU MET SER GLY LEU GLU VAL SER PHE GLU GLU LEU SEQRES 2 C 175 ARG THR PHE GLY GLY HIS ASP ALA LYS PHE ILE ASP SER SEQRES 3 C 175 LEU GLN GLU ASN GLU PHE ARG LEU TYR TYR TYR ASN LYS SEQRES 4 C 175 PHE LYS ASP ILE ALA SER THR LEU ASN LYS ALA LYS SER SEQRES 5 C 175 ILE VAL GLY THR THR ALA SER LEU GLN TYR MET LYS ASN SEQRES 6 C 175 VAL PHE LYS GLU LYS TYR LEU LEU SER GLU ASP THR SER SEQRES 7 C 175 GLY LYS PHE SER VAL ASP LYS LEU LYS PHE ASP LYS LEU SEQRES 8 C 175 TYR LYS MET LEU THR GLU ILE TYR THR GLU ASP ASN PHE SEQRES 9 C 175 VAL LYS PHE PHE LYS VAL LEU ASN ARG LYS THR TYR LEU SEQRES 10 C 175 ASN PHE ASP LYS ALA VAL PHE LYS ILE ASN ILE VAL PRO SEQRES 11 C 175 LYS VAL ASN TYR THR ILE TYR ASP GLY PHE ASN LEU ARG SEQRES 12 C 175 ASN THR ASN LEU ALA ALA ASN PHE ASN GLY GLN ASN THR SEQRES 13 C 175 GLU ILE ASN ASN MET ASN PHE THR LYS LEU LYS ASN PHE SEQRES 14 C 175 THR GLY LEU PHE GLU PHE HET ZN B 251 1 HETNAM ZN ZINC ION FORMUL 4 ZN ZN 2+ FORMUL 5 HOH *70(H2 O) HELIX 1 1 GLY A 38 ARG A 42 5 5 HELIX 2 2 GLU A 76 GLU A 79 5 4 HELIX 3 3 THR A 117 ILE A 124 1 8 HELIX 4 4 ILE B 24 GLY B 28 5 5 HELIX 5 5 THR B 80 SER B 100 1 21 HELIX 6 6 THR B 101 GLY B 114 1 14 HELIX 7 7 ILE B 130 THR B 132 5 3 HELIX 8 8 ASP B 216 TYR B 233 1 18 HELIX 9 9 PHE C 260 GLY C 267 1 8 HELIX 10 10 GLY C 268 ILE C 274 5 7 HELIX 11 11 ASP C 275 ALA C 300 1 26 HELIX 12 12 SER C 309 TYR C 321 1 13 HELIX 13 13 ASP C 334 GLU C 347 1 14 HELIX 14 14 THR C 350 LYS C 359 1 10 HELIX 15 15 PHE C 401 ASN C 405 5 5 HELIX 16 16 ASN C 409 PHE C 413 5 5 SHEET 1 A 4 GLN A 6 SER A 10 0 SHEET 2 A 4 LEU A 21 SER A 28 -1 O SER A 28 N GLN A 6 SHEET 3 A 4 MET A 92 ALA A 97 -1 O LEU A 95 N LEU A 23 SHEET 4 A 4 SER A 83 ARG A 86 -1 N SER A 85 O PHE A 94 SHEET 1 B 6 GLY A 13 GLN A 16 0 SHEET 2 B 6 THR A 134 SER A 139 1 O LEU A 135 N GLY A 13 SHEET 3 B 6 ALA A 106 ASP A 113 -1 N TYR A 108 O THR A 134 SHEET 4 B 6 ALA A 47 GLN A 53 -1 N PHE A 51 O TYR A 109 SHEET 5 B 6 ARG A 59 ILE A 65 -1 O ILE A 65 N MET A 48 SHEET 6 B 6 THR A 72 TYR A 74 -1 O TYR A 73 N ALA A 64 SHEET 1 C 4 GLY A 13 GLN A 16 0 SHEET 2 C 4 THR A 134 SER A 139 1 O LEU A 135 N GLY A 13 SHEET 3 C 4 ALA A 106 ASP A 113 -1 N TYR A 108 O THR A 134 SHEET 4 C 4 HIS A 129 TRP A 130 -1 O HIS A 129 N ALA A 112 SHEET 1 D 8 TYR B 144 GLU B 148 0 SHEET 2 D 8 CYS B 134 ILE B 138 -1 N ILE B 135 O GLU B 147 SHEET 3 D 8 ILE B 19 LYS B 23 -1 N LYS B 23 O ASN B 136 SHEET 4 D 8 VAL B 33 HIS B 39 -1 O ALA B 35 N ALA B 20 SHEET 5 D 8 ILE B 42 ARG B 48 -1 O VAL B 44 N PHE B 36 SHEET 6 D 8 LEU B 151 GLY B 155 1 O ILE B 153 N ILE B 45 SHEET 7 D 8 GLN B 184 ARG B 187 1 O ILE B 186 N ILE B 154 SHEET 8 D 8 GLU B 164 SER B 167 -1 N GLU B 164 O ARG B 187 SHEET 1 E 2 GLU B 126 LEU B 127 0 SHEET 2 E 2 SER C 302 ILE C 303 1 O SER C 302 N LEU B 127 SHEET 1 F 4 LYS B 212 ALA B 214 0 SHEET 2 F 4 PHE B 192 GLU B 197 -1 N PHE B 196 O PHE B 213 SHEET 3 F 4 VAL C 373 LYS C 375 -1 O PHE C 374 N THR B 193 SHEET 4 F 4 THR C 414 LYS C 415 -1 O THR C 414 N LYS C 375 SHEET 1 G 2 VAL B 242 ASN B 246 0 SHEET 2 G 2 GLY C 255 SER C 259 -1 O LEU C 256 N VAL B 245 SHEET 1 H 2 SER C 324 GLU C 325 0 SHEET 2 H 2 PHE C 331 SER C 332 -1 O SER C 332 N SER C 324 SSBOND 1 CYS A 25 CYS A 110 1555 1555 2.04 LINK NE2 HIS B 223 ZN ZN B 251 1555 1555 2.02 LINK NE2 HIS B 227 ZN ZN B 251 1555 1555 2.13 LINK OE1 GLU C 262 ZN ZN B 251 1555 1555 1.89 LINK OE2 GLU C 262 ZN ZN B 251 1555 1555 2.45 CISPEP 1 ILE A 124 PRO A 125 0 4.07 SITE 1 AC1 4 HIS B 223 HIS B 227 TYR B 250 GLU C 262 CRYST1 168.282 48.764 103.643 90.00 116.75 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005942 0.000000 0.002995 0.00000 SCALE2 0.000000 0.020507 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010805 0.00000